Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States

Abstract Introduction Clinical Alzheimer’s disease (AD) begins with mild cognitive impairment (MCI) and progresses to mild, moderate, or severe dementia, constituting a disease continuum that eventually leads to death. This study aimed to estimate the probabilities of transitions across those diseas...

Full description

Bibliographic Details
Main Authors: Amir Abbas Tahami Monfared, Shuai Fu, Noemi Hummel, Luyuan Qi, Aastha Chandak, Raymond Zhang, Quanwu Zhang
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-05-01
Series:Neurology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40120-023-00498-1
_version_ 1797555531116707840
author Amir Abbas Tahami Monfared
Shuai Fu
Noemi Hummel
Luyuan Qi
Aastha Chandak
Raymond Zhang
Quanwu Zhang
author_facet Amir Abbas Tahami Monfared
Shuai Fu
Noemi Hummel
Luyuan Qi
Aastha Chandak
Raymond Zhang
Quanwu Zhang
author_sort Amir Abbas Tahami Monfared
collection DOAJ
description Abstract Introduction Clinical Alzheimer’s disease (AD) begins with mild cognitive impairment (MCI) and progresses to mild, moderate, or severe dementia, constituting a disease continuum that eventually leads to death. This study aimed to estimate the probabilities of transitions across those disease states. Methods We developed a mixed-effects multi-state Markov model to estimate the transition probabilities, adjusted for 5 baseline covariates, using the Health and Retirement Study (HRS) database. HRS surveys older adults in the United States bi-annually. Alzheimer states were defined using the modified Telephone Interview of Cognitive Status (TICS-m). Results A total of 11,292 AD patients were analyzed. Patients were 70.8 ± 9.0 years old, 54.9% female, and with 12.0 ± 3.3 years of education. Within 1 year from the initial state, the model estimated a higher probability of transition to the next AD state in earlier disease: 12.8% from MCI to mild AD and 5.0% from mild to moderate AD, but < 1% from moderate to severe AD. After 10 years, the probability of transition to the next state was markedly higher for all states, but still higher in earlier disease: 29.8% from MCI to mild AD, 23.5% from mild to moderate AD, and 5.7% from moderate to severe AD. Across all AD states, the probability of transition to death was < 5% after 1 year and > 15% after 10 years. Older age, fewer years of education, unemployment, and nursing home stay were associated with a higher risk of disease progression (p < 0.01). Conclusions This analysis shows that the risk of progression is greater in earlier AD states, increases over time, and is higher in patients who are older, with fewer years of education, unemployed, or in a nursing home at baseline. The estimated transition probabilities can provide guidance for future disease management and clinical trial design optimization, and can be used to refine existing cost-effectiveness frameworks.
first_indexed 2024-03-10T16:49:53Z
format Article
id doaj.art-7710e9f88ab940b99a24539ccd7e6330
institution Directory Open Access Journal
issn 2193-8253
2193-6536
language English
last_indexed 2024-03-10T16:49:53Z
publishDate 2023-05-01
publisher Adis, Springer Healthcare
record_format Article
series Neurology and Therapy
spelling doaj.art-7710e9f88ab940b99a24539ccd7e63302023-11-20T11:21:41ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362023-05-011241235125510.1007/s40120-023-00498-1Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United StatesAmir Abbas Tahami Monfared0Shuai Fu1Noemi Hummel2Luyuan Qi3Aastha Chandak4Raymond Zhang5Quanwu Zhang6Eisai Inc.Certara, Integrated Drug DevelopmentCertara GmbHCertara SarlCertara Inc.Eisai Inc.Eisai Inc.Abstract Introduction Clinical Alzheimer’s disease (AD) begins with mild cognitive impairment (MCI) and progresses to mild, moderate, or severe dementia, constituting a disease continuum that eventually leads to death. This study aimed to estimate the probabilities of transitions across those disease states. Methods We developed a mixed-effects multi-state Markov model to estimate the transition probabilities, adjusted for 5 baseline covariates, using the Health and Retirement Study (HRS) database. HRS surveys older adults in the United States bi-annually. Alzheimer states were defined using the modified Telephone Interview of Cognitive Status (TICS-m). Results A total of 11,292 AD patients were analyzed. Patients were 70.8 ± 9.0 years old, 54.9% female, and with 12.0 ± 3.3 years of education. Within 1 year from the initial state, the model estimated a higher probability of transition to the next AD state in earlier disease: 12.8% from MCI to mild AD and 5.0% from mild to moderate AD, but < 1% from moderate to severe AD. After 10 years, the probability of transition to the next state was markedly higher for all states, but still higher in earlier disease: 29.8% from MCI to mild AD, 23.5% from mild to moderate AD, and 5.7% from moderate to severe AD. Across all AD states, the probability of transition to death was < 5% after 1 year and > 15% after 10 years. Older age, fewer years of education, unemployment, and nursing home stay were associated with a higher risk of disease progression (p < 0.01). Conclusions This analysis shows that the risk of progression is greater in earlier AD states, increases over time, and is higher in patients who are older, with fewer years of education, unemployed, or in a nursing home at baseline. The estimated transition probabilities can provide guidance for future disease management and clinical trial design optimization, and can be used to refine existing cost-effectiveness frameworks.https://doi.org/10.1007/s40120-023-00498-1Alzheimer’s diseaseDisease progressionMixed-effects modelMulti-state Markov modelTICS-mTransition probability
spellingShingle Amir Abbas Tahami Monfared
Shuai Fu
Noemi Hummel
Luyuan Qi
Aastha Chandak
Raymond Zhang
Quanwu Zhang
Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
Neurology and Therapy
Alzheimer’s disease
Disease progression
Mixed-effects model
Multi-state Markov model
TICS-m
Transition probability
title Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
title_full Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
title_fullStr Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
title_full_unstemmed Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
title_short Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States
title_sort estimating transition probabilities across the alzheimer s disease continuum using a nationally representative real world database in the united states
topic Alzheimer’s disease
Disease progression
Mixed-effects model
Multi-state Markov model
TICS-m
Transition probability
url https://doi.org/10.1007/s40120-023-00498-1
work_keys_str_mv AT amirabbastahamimonfared estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT shuaifu estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT noemihummel estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT luyuanqi estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT aasthachandak estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT raymondzhang estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates
AT quanwuzhang estimatingtransitionprobabilitiesacrossthealzheimersdiseasecontinuumusinganationallyrepresentativerealworlddatabaseintheunitedstates